Calcutta High Court Reverses Rejection of Pharmacyclics’ Divisional Patent on Ibrutinib Combination Therapy

Court clarifies Indian patent law on divisional applications, ordering fresh examination of divisional claims for cancer treatment involving ibrutinib and anti-CD20 antibodies

IIPLA News Desk•anonymous access•0 articles left this week

Calcutta High Court Reverses Rejection of Pharmacyclics’ Divisional Patent on Ibrutinib Combination Therapy

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The Calcutta High Court has set aside the Indian Patent Office’s rejection of Pharmacyclics LLC’s divisional patent application covering a combination therapy of ibrutinib with anti-CD20 antibodies for hematological malignancies. The ruling affirms that divisional applications are maintainable when supported by the pa…

Share This Article

Ready-to-post copy includes the article link.

Calcutta High Court Reverses Rejection of Pharmacyclics’ Divisional Patent on Ibrutinib Combination Therapy The Calcutta High Court has set aside the Indian Patent Office’s rejection of Pharmacyclics LLC’s divisional patent application covering a combination therapy of ibrutinib with anti-CD20 antibodies for hematological mal... Read the full IIPLA article: https://iipla.org/news/calcutta-high-court-reverses-rejection-of-pharmacyclics-divisional-patent-on-ibrutinib-combination-therapy

LinkedIn X Facebook WhatsApp Telegram Email

Related Coverage

Continue in the newsroom

Back to newsroom

PatentsGlobal

South Korea’s Current Account Surplus with U.S. Declines for First Time in Six Years Amid Rising Intellectual Property Payments

South Korea’s current account surplus hit a record $123.05 billion in 2023, driven by strong exports and investment income. However, the surplus with the United States fell for the first time in six years due to a widening services deficit from higher intellectual property payments and reduced exports of key tariff it…

Friday, June 19, 2026

PatentsIndia

Maharashtra Greenlights Rs 60 Crore MANTRA Centre to Boost Patent Filing and Research Commercialisation

The Maharashtra government has approved Rs 60 crore for establishing the Maharashtra Academy for Nurturing Technology, Research and Intellectual Assets (MANTRA). Scheduled to begin operations from July 1 at the University of Mumbai, MANTRA aims to support patent filing, intellectual property management, and research c…

Friday, June 19, 2026

PatentsGlobal

Dr. Natalie Callis and Quintessential Consulting Unveil LYQOR™ to Advance Human Intelligence Governance

Dr. Natalie Callis and Quintessential Consulting LLC have introduced LYQOR™, a new governance infrastructure focused on Human Intelligence Governance™. This initiative aims to license, protect, and develop intellectual property related to leadership and decision-making frameworks that address human factors in high-sta…

Friday, June 19, 2026

PatentsUSA

Maryland Exercises Right of First Refusal to Acquire Preakness Stakes Intellectual Property, Blocking Churchill Downs’ $85M Bid

Maryland has invoked its statutory right of first refusal to purchase the intellectual property rights of the Preakness Stakes and Black-Eyed Susan Stakes from 1/ST Maryland LLC. This move effectively halts Churchill Downs’ $85 million offer made in April to acquire the IP. Governor Wes Moore emphasized the importance…

Thursday, June 18, 2026

PatentsUSA

Maryland Allocates $85 Million to Acquire Preakness Stakes and Black-Eyed Susan IP Rights

Maryland is investing $85 million to obtain intellectual property rights for the Preakness Stakes and Black-Eyed Susan, matching a prior bid from Churchill Downs. The acquisition, funded through a tax-exempt bond, aims to protect the state's horseracing legacy and reduce future licensing costs.

Thursday, June 18, 2026

PatentsUSA

Maryland Exercises Right to Match $85 Million Offer for Preakness Stakes Intellectual Property

Maryland has announced its intent to match an $85 million bid by Churchill Downs Inc. to acquire the intellectual property rights of the Preakness Stakes and Black-Eyed Susan Stakes. By exercising its right of first refusal, Maryland aims to retain ownership of these iconic racing assets, ensuring long-term control ov…

Thursday, June 18, 2026